Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

Market Cap	2.75B -31.5%
Revenue (ttm)	590.94M -9.9%
Net Income	-17.53M
EPS	-0.08
Shares Out	198.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,462,430
Open	13.78
Previous Close	13.73
Day's Range	13.72 - 13.88
52-Week Range	12.62 - 22.97
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real es...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1909
• Employees: 1,119
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603896

Financial Performance

In 2025, SHA:603896's revenue was 640.18 million, a decrease of -9.21% compared to the previous year's 705.11 million. Earnings were 18.17 million, a decrease of -89.58%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 5, 2026

Data Sources Report a data error